-- 3M Food Collaboration. On November 8, Gen-Probe announced that 3M
informed the Company it no longer intends to fund the companies'
collaboration to develop rapid molecular assays for the food testing
industry. The collaboration has since been formally terminated.
Despite the termination, Gen-Probe received milestone payments of
$2 million in the fourth quarter of 2007 associated with achieving
technological feasibility for potential food testing assays.
Gen-Probe retains the rights to commercialize these assays.
-- First MilliPROBE(TM) Test. On January 8, Millipore and Gen-Probe
announced the launch of the first product from their collaboration to
create faster, sensitive, more robust tests for detecting contaminants
in pharmaceutical and biotechnology manufacturing processes. The
MilliPROBE system is the first solution of its kind for
biopharmaceutical manufacturing. It combines Millipore's leading,
industry-accepted sample prep methodologies with Gen-Probe's advanced,
proven nucleic acid technologies to deliver both speed and sensitivity
in one microbial screening tool. The MilliPROBE system uses Real-Time
Transcription-Mediated Amplification (RT TMA) technology to detect
targeted microbial contamination within hours compared to the days or
weeks usually required to generate results using traditional
culture-based methods. The collaboration's first MilliPROBE assay
targets the bacterium Pseudomonas aeruginosa and is designed as an
in-process, early warning system to provide faster, more effective
detection of the bacterium in purified water used during drug
-- Purchase of Blood Screening Manufacturing Plant. On February 1,
Gen-Probe purchased for $15.7 million its blo
|SOURCE Gen-Probe Incorporated|
Copyright©2008 PR Newswire.
All rights reserved